Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:29 pm Purchase | 2022-12-31 | 13G | ZYMEWORKS INC ZYME | Redmile Group, LLC | 6,175,918 9.800% | 100,000 (+1.65%) | Filing History |
| 2023-02-14 4:29 pm Sale | 2022-12-31 | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group, LLC | 2,684,396 6.400% | -105,100 (-3.77%) | Filing History |
| 2023-02-14 4:28 pm Purchase | 2022-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Redmile Group, LLC | 3,878,599 8.000% | 795,098 (+25.79%) | Filing History |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Redmile Group, LLC | 2,673,837 4.900% | 86,107 (+3.33%) | Filing History |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | KRYSTAL BIOTECH INC KRYS | Redmile Group, LLC | 1,896,645 7.400% | 75,747 (+4.16%) | Filing History |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group, LLC | 1,854,108 5.900% | -100,312 (-5.13%) | Filing History |
| 2023-02-14 4:23 pm Purchase | 2022-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Redmile Group, LLC | 2,632,912 5.600% | 1,030,627 (+64.32%) | Filing History |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | REPLIMUNE GROUP INC REPL | Redmile Group, LLC | 5,740,099 9.900% | 574,968 (+11.13%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | RAPT THERAPEUTICS INC RAPT | Redmile Group, LLC | 459,980 9.900% | 60,060 (+15.02%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group, LLC | 4,899,772 9.900% | 1,941,488 (+65.63%) | Filing History |
| 2023-02-14 4:21 pm Sale | 2022-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Redmile Group, LLC | 151,528 6.900% | -64,550 (-29.87%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | IMMUNOGEN INC IMGN | Redmile Group, LLC | 19,896,453 8.600% | 274,472 (+1.40%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group, LLC | 8,483,322 9.900% | 1,217,808 (+16.76%) | Filing History |
| 2023-02-14 4:19 pm Purchase | 2022-12-31 | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group, LLC | 7,108,097 9.900% | 1,427,180 (+25.12%) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group, LLC | 393,500 9.900% | 29,551 (+8.12%) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Redmile Group, LLC | 4,897,575 9.900% | 5,882 (+0.12%) | Filing History |
| 2023-02-14 4:16 pm Purchase | 2022-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | Redmile Group, LLC | 28,599,494 9.900% | 194,452 (+0.68%) | Filing History |
| 2023-02-10 5:18 pm Purchase | 2022-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 13,565,249 16.800% | 6,114,220 (+82.06%) | Filing History |
| 2023-02-08 5:18 pm Purchase | 2023-01-19 | 13G | ADVAXIS INC PAR $0.001 ADXS | Redmile Group, LLC | 332,353 6.800% | 332,353 (New Position) | Filing History |
| 2023-02-08 5:16 pm Sale | 2022-12-31 | 13G | AYALA PHARMACEUTICALS INC AYLA | Redmile Group, LLC | 0 0.000% | -1,472,522 (Position Closed) | Filing History |